Cargando…
Phenotypic alterations in type II alveolar epithelial cells in CD4(+ )T cell mediated lung inflammation
BACKGROUND: Although the contribution of alveolar type II epithelial cell (AEC II) activities in various aspects of respiratory immune regulation has become increasingly appreciated, our understanding of the contribution of AEC II transcriptosome in immunopathologic lung injury remains poorly unders...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1939847/ https://www.ncbi.nlm.nih.gov/pubmed/17610738 http://dx.doi.org/10.1186/1465-9921-8-47 |
_version_ | 1782134409447604224 |
---|---|
author | Gereke, Marcus Gröbe, Lothar Prettin, Silvia Kasper, Michael Deppenmeier, Stefanie Gruber, Achim D Enelow, Richard I Buer, Jan Bruder, Dunja |
author_facet | Gereke, Marcus Gröbe, Lothar Prettin, Silvia Kasper, Michael Deppenmeier, Stefanie Gruber, Achim D Enelow, Richard I Buer, Jan Bruder, Dunja |
author_sort | Gereke, Marcus |
collection | PubMed |
description | BACKGROUND: Although the contribution of alveolar type II epithelial cell (AEC II) activities in various aspects of respiratory immune regulation has become increasingly appreciated, our understanding of the contribution of AEC II transcriptosome in immunopathologic lung injury remains poorly understood. We have previously established a mouse model for chronic T cell-mediated pulmonary inflammation in which influenza hemagglutinin (HA) is expressed as a transgene in AEC II, in mice expressing a transgenic T cell receptor specific for a class II-restricted epitope of HA. Pulmonary inflammation in these mice occurs as a result of CD4(+ )T cell recognition of alveolar antigen. This model was utilized to assess the profile of inflammatory mediators expressed by alveolar epithelial target cells triggered by antigen-specific recognition in CD4(+ )T cell-mediated lung inflammation. METHODS: We established a method that allows the flow cytometric negative selection and isolation of primary AEC II of high viability and purity. Genome wide transcriptional profiling was performed on mRNA isolated from AEC II isolated from healthy mice and from mice with acute and chronic CD4(+ )T cell-mediated pulmonary inflammation. RESULTS: T cell-mediated inflammation was associated with expression of a broad array of cytokine and chemokine genes by AEC II cell, indicating a potential contribution of epithelial-derived chemoattractants to the inflammatory cell parenchymal infiltration. Morphologically, there was an increase in the size of activated epithelial cells, and on the molecular level, comparative transcriptome analyses of AEC II from inflamed versus normal lungs provide a detailed characterization of the specific inflammatory genes expressed in AEC II induced in the context of CD4(+ )T cell-mediated pneumonitis. CONCLUSION: An important contribution of AEC II gene expression to the orchestration and regulation of interstitial pneumonitis is suggested by the panoply of inflammatory genes expressed by this cell population, and this may provide insight into the molecular pathogenesis of pulmonary inflammatory states. CD4(+ )T cell recognition of antigen presented by AEC II cells appears to be a potent trigger for activation of the alveolar cell inflammatory transcriptosome. |
format | Text |
id | pubmed-1939847 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2007 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-19398472007-08-04 Phenotypic alterations in type II alveolar epithelial cells in CD4(+ )T cell mediated lung inflammation Gereke, Marcus Gröbe, Lothar Prettin, Silvia Kasper, Michael Deppenmeier, Stefanie Gruber, Achim D Enelow, Richard I Buer, Jan Bruder, Dunja Respir Res Research BACKGROUND: Although the contribution of alveolar type II epithelial cell (AEC II) activities in various aspects of respiratory immune regulation has become increasingly appreciated, our understanding of the contribution of AEC II transcriptosome in immunopathologic lung injury remains poorly understood. We have previously established a mouse model for chronic T cell-mediated pulmonary inflammation in which influenza hemagglutinin (HA) is expressed as a transgene in AEC II, in mice expressing a transgenic T cell receptor specific for a class II-restricted epitope of HA. Pulmonary inflammation in these mice occurs as a result of CD4(+ )T cell recognition of alveolar antigen. This model was utilized to assess the profile of inflammatory mediators expressed by alveolar epithelial target cells triggered by antigen-specific recognition in CD4(+ )T cell-mediated lung inflammation. METHODS: We established a method that allows the flow cytometric negative selection and isolation of primary AEC II of high viability and purity. Genome wide transcriptional profiling was performed on mRNA isolated from AEC II isolated from healthy mice and from mice with acute and chronic CD4(+ )T cell-mediated pulmonary inflammation. RESULTS: T cell-mediated inflammation was associated with expression of a broad array of cytokine and chemokine genes by AEC II cell, indicating a potential contribution of epithelial-derived chemoattractants to the inflammatory cell parenchymal infiltration. Morphologically, there was an increase in the size of activated epithelial cells, and on the molecular level, comparative transcriptome analyses of AEC II from inflamed versus normal lungs provide a detailed characterization of the specific inflammatory genes expressed in AEC II induced in the context of CD4(+ )T cell-mediated pneumonitis. CONCLUSION: An important contribution of AEC II gene expression to the orchestration and regulation of interstitial pneumonitis is suggested by the panoply of inflammatory genes expressed by this cell population, and this may provide insight into the molecular pathogenesis of pulmonary inflammatory states. CD4(+ )T cell recognition of antigen presented by AEC II cells appears to be a potent trigger for activation of the alveolar cell inflammatory transcriptosome. BioMed Central 2007 2007-07-04 /pmc/articles/PMC1939847/ /pubmed/17610738 http://dx.doi.org/10.1186/1465-9921-8-47 Text en Copyright © 2007 Gereke et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Gereke, Marcus Gröbe, Lothar Prettin, Silvia Kasper, Michael Deppenmeier, Stefanie Gruber, Achim D Enelow, Richard I Buer, Jan Bruder, Dunja Phenotypic alterations in type II alveolar epithelial cells in CD4(+ )T cell mediated lung inflammation |
title | Phenotypic alterations in type II alveolar epithelial cells in CD4(+ )T cell mediated lung inflammation |
title_full | Phenotypic alterations in type II alveolar epithelial cells in CD4(+ )T cell mediated lung inflammation |
title_fullStr | Phenotypic alterations in type II alveolar epithelial cells in CD4(+ )T cell mediated lung inflammation |
title_full_unstemmed | Phenotypic alterations in type II alveolar epithelial cells in CD4(+ )T cell mediated lung inflammation |
title_short | Phenotypic alterations in type II alveolar epithelial cells in CD4(+ )T cell mediated lung inflammation |
title_sort | phenotypic alterations in type ii alveolar epithelial cells in cd4(+ )t cell mediated lung inflammation |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1939847/ https://www.ncbi.nlm.nih.gov/pubmed/17610738 http://dx.doi.org/10.1186/1465-9921-8-47 |
work_keys_str_mv | AT gerekemarcus phenotypicalterationsintypeiialveolarepithelialcellsincd4tcellmediatedlunginflammation AT grobelothar phenotypicalterationsintypeiialveolarepithelialcellsincd4tcellmediatedlunginflammation AT prettinsilvia phenotypicalterationsintypeiialveolarepithelialcellsincd4tcellmediatedlunginflammation AT kaspermichael phenotypicalterationsintypeiialveolarepithelialcellsincd4tcellmediatedlunginflammation AT deppenmeierstefanie phenotypicalterationsintypeiialveolarepithelialcellsincd4tcellmediatedlunginflammation AT gruberachimd phenotypicalterationsintypeiialveolarepithelialcellsincd4tcellmediatedlunginflammation AT enelowrichardi phenotypicalterationsintypeiialveolarepithelialcellsincd4tcellmediatedlunginflammation AT buerjan phenotypicalterationsintypeiialveolarepithelialcellsincd4tcellmediatedlunginflammation AT bruderdunja phenotypicalterationsintypeiialveolarepithelialcellsincd4tcellmediatedlunginflammation |